ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,082, issued on March 17, was assigned to CITY OF HOPE (Duarte, Calif.).

"METTL16 inhibitors and uses thereof" was invented by Jianjun Chen (Temple City, Calif.), Xiaolan Deng (Temple City, Calif.), Li Han (Monrovia, Calif.), Hongzhi Li (Diamond Bar, Calif.) and Rui Su (Monrovia, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides, inter alia, METTL16 inhibitors and methods of treating cancers that overexpress METTL16."

The patent was filed on Aug. 20, 2020, under Application No. 17/632,963.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Se...